Nutritionally-induced catch-up growth

Nutrients

Volumn 7, Issue 1, 2015, Pages 517-551

  Gat Yablonski, Galia ^a   Phillip, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Catch up growth; Growth; Growth plate; Nutrition

Indexed keywords

DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID; GROWTH HORMONE; HISTONE DEACETYLASE; HYDROCORTISONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PREDNISONE; SIRTUIN 1; SIRTUIN 6; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; THYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR; FIBROBLAST GROWTH FACTOR; HIF1A PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

AUTOPHAGY; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CATCH UP GROWTH; CELL MATURATION; CELL PROLIFERATION; EPIGENETICS; GROWTH PLATE; HUMAN; HYPOTHYROIDISM; MALNUTRITION; METABOLIC REGULATION; NONHUMAN; NUTRITION; OSSIFICATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHILD; COMPLICATION; DIET THERAPY; GENETICS; GROWTH DISORDERS; INFANT; METABOLISM; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTOPHAGY; CHILD; EPIGENOMICS; FIBROBLAST GROWTH FACTORS; GLUCOCORTICOIDS; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFANT; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALNUTRITION; MICRORNAS; NUTRITIONAL STATUS; THYROID HORMONES; TOR SERINE-THREONINE KINASES; VITAMIN D;

EID: 84921502283     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7010517     Document Type: Review

References (226)

1. Joint UNICEF-WHO-The World Bank Child Malnutrition Database: Estimates for 2012 and Launch of Interactive Data Dashboards. Available online: http://www.who.int/nutgrowthdb/jme_ 2012_summary_note_v2.pdf (accessed on 17 September 2014).
2. Maeda, Y.; Nakamura, E.; Nguyen, M.T.; Suva, L.J.; Swain, F.L.; Razzaque, M.S.; Mackem, S.; Lanske, B. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc. Natl. Acad. Sci. USA 2007, 104, 6382-6387.
3. Mackie, E.J.; Tatarczuch, L.; Mirams, M. The skeleton: A multi-functional complex organ: The growth plate chondrocyte and endochondral ossification. J. Endocrinol. 2011, 211, 109-121.
4. Boyan, B.D.; Wong, K.L.; Fang, M.; Schwartz, Z. 1α,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. J. Steroid Biochem. Mol. Biol. 2007, 103, 467-472.
5. Heinrichs, C.; Colli, M.; Yanovski, J.A.; Laue, L.; Gerstl, N.A.; Kramer, A.D.; Uyeda, J.A.; Baron, J. Effects of fasting on the growth plate: Systemic and local mechanisms. Endocrinology 1997, 138, 5359-5365.
6. Farnum, C.E.; Lee, A.O.; O'Hara, K.; Wilsman, N.J. Effect of short-term fasting on bone elongation rates: An analysis of catch-up growth in young male rats. Pediatr. Res. 2003, 53, 33-41.
7. Even-Zohar, N.; Jacob, J.; Amariglio, N.; Rechavi, G.; Potievsky, O.; Phillip, M.; Gat-Yablonski, G. Nutrition-induced catch-up growth increases hypoxia inducible factor 1α RNA levels in the growth plate. Bone 2008, 42, 505-515.
8. Torun, B.; Chew, F. Protein energy malnutrition. In Modern Nutrition in Health and Disease, 8th ed.; Shils, M.E., Olson, J., Shike, M., Ross, C., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 1994; pp. 950-966.
9. Soliman, A.T.; ElZalabany, M.M.; Salama, M.; Ansari, B.M. Serum leptin concentrations during severe protein-energy malnutrition: Correlation with growth parameters and endocrine function. Metabolism 2000, 49, 819-825.
10. Kilic, M.; Taskin, E.; Ustundag, B.; Aygun, A.D. The evaluation of serum leptin level and other hormonal parameters in children with severe malnutrition. Clin. Biochem. 2004, 37, 382-387.
11. Zadik, Z.; Sinai, T.; Zung, A.; Reifen, R. Effect of nutrition on growth in short stature before and during growth-hormone therapy. Pediatrics 2005, 116, 68-72.
12. Favaro, A.; Tenconi, E.; Degortes, D.; Soave, M.; Zanetti, T.; Nardi, M.T.; Caregaro, L.; Santonastaso, P. Association between low height and eating disorders: Cause or effect? Int. J. Eat. Disord. 2007, 40, 549-553.
13. Boersma, B.; Houwen, R.H.; Blum, W.F.; van Doorn, J.; Wit, J.M. Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm. Res. 2002, 58, 57-65.
14. Lui, J.C.; Nilsson, O.; Baron, J. Growth plate senescence and catch-up growth. Endocr. Dev. 2011, 21, 23-29.
15. Prader, A.; Tanner, J.M.; von, H.G. Catch-up growth following illness or starvation. An example of developmental canalization in man. J. Pediatr. 1963, 62, 646-659.
16. Nilsson, O.; Baron, J. Impact of growth plate senescence on catch-up growth and epiphyseal fusion. Pediatr. Nephrol. 2005, 20, 319-322.
17. Baron, J.; Klein, K.O.; Colli, M.J.; Yanovski, J.A.; Novosad, J.A.; Bacher, J.D.; Cutler, G.B., Jr. Catch-up growth after glucocorticoid excess: A mechanism intrinsic to the growth plate. Endocrinology 1994, 135, 1367-1371.
18. Marino, R.; Hegde, A.; Barnes, K.M.; Schrier, L.; Emons, J.A.; Nilsson, O.; Baron, J. Catch-up growth after hypothyroidism is caused by delayed growth plate senescence. Endocrinology 2008, 149, 1820-1828.
19. Gafni, R.I.; Weise, M.; Robrecht, D.T.; Meyers, J.L.; Barnes, K.M.; De-Levi, S.; Baron, J. Catch-up growth is associated with delayed senescence of the growth plate in rabbits. Pediatr. Res. 2001, 50, 618-623.
20. Gat-Yablonski, G.; Phillip, M. Leptin and regulation of linear growth. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 303-308.
21. Pando, R.; Even-Zohar, N.; Shtaif, B.; Edry, L.; Shomron, N.; Phillip, M.; Gat-Yablonski, G. MicroRNAs in the growth plate are responsive to nutritional cues: Association between miR-140 and SIRT1. J. Nutr. Biochem. 2012, 23, 1474-1481.
22. Schwartz, M.W.; Woods, S.C.; Porte, D., Jr.; Seeley, R.J.; Baskin, D.G. Central nervous system control of food intake. Nature 2000, 404, 661-671.
23. Baumeister, F.A.; Engelsberger, I.; Schulze, A. Pancreatic agenesis as cause for neonatal diabetes mellitus. Klin. Padiatr. 2005, 217, 76-81.
24. Taylor, S.I. Lilly lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992, 41, 1473-1490.
25. Walenkamp, M.J.; Wit, J.M. Single gene mutations causing SGA. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22, 433-446.
26. Krook, A.; O'Rahilly, S. Mutant insulin receptors in syndromes of insulin resistance. Baillieres Clin. Endocrinol. Metab. 1996, 10, 97-122.
27. Hattersley, A.T.; Beards, F.; Ballantyne, E.; Appleton, M.; Harvey, R.; Ellard, S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat. Genet. 1998, 19, 268-270.
28. Rosenfeld, R.; Cohen, P. Disorders of growth hormone/insulin like growth factor secretion and action in pediatric endocrinology. In Pediatric Endocrinology; Sperling, M., Ed.; Saunders: Philadelphia, PA, USA, 2002; pp. 211-288.
29. Cosmi, E.; Fanelli, T.; Visentin, S.; Trevisanuto, D.; Zanardo, V. Consequences in infants that were intrauterine growth restricted. J. Pregnancy 2011, 2011, 364381.
30. Berends, L.M.; Fernandez-Twinn, D.S.; Martin-Gronert, M.S.; Cripps, R.L.; Ozanne, S.E. Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int. J. Obes. 2013, 37, 1051-1057.
31. Deng, H.Z.; Deng, H.; Su, Z.; Li, Y.H.; Ma, H.M.; Chen, H.S.; Du, M.L. Insulin resistance and adiponectin levels are associated with height catch-up growth in pre-pubertal Chinese individuals born small for gestational age. Nutr. Metab. 2012, 9, 107.
32. Jou, M.Y.; Lonnerdal, B.; Griffin, I.J. Effects of early postnatal growth restriction and subsequent catch-up growth on body composition, insulin sensitivity, and behavior in neonatal rats. Pediatr. Res. 2013, 73, 596-601.
33. Baker, J.; Liu, J.P.; Robertson, E.J.; Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75, 73-82.
34. Hunziker, E.B.; Wagner, J.; Zapf, J. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J. Clin. Investig. 1994, 93, 1078-1086.
35. Cruickshank, J.; Grossman, D.I.; Peng, R.K.; Famula, T.R.; Oberbauer, A.M. Spatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate development. J. Endocrinol. 2005, 184, 543-553.
36. Liu, J.P.; Baker, J.; Perkins, A.S.; Robertson, E.J.; Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75, 59-72.
37. Woods, K.A.; Camacho-Hubner, C.; Savage, M.O.; Clark, A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 1996, 335, 1363-1367.
38. Abuzzahab, M.J.; Schneider, A.; Goddard, A.; Grigorescu, F.; Lautier, C.; Keller, E.; Kiess, W.; Klammt, J.; Kratzsch, J.; Osgood, D.; et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N. Engl. J. Med. 2003, 349, 2211-2222.
39. Raile, K.; Klammt, J.; Schneider, A.; Keller, A.; Laue, S.; Smith, R.; Pfaffle, R.; Kratzsch, J.; Keller, E.; Kiess, W. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor I receptor (IGF1R) mutation: Implications for a gene dosage effect of the human IGF1R. J. Clin. Endocrinol. Metab. 2006, 91, 2264-2271.
40. Inagaki, K.; Tiulpakov, A.; Rubtsov, P.; Sverdlova, P.; Peterkova, V.; Yakar, S.; Terekhov, S.; LeRoith, D. A familial insulin-like growth factor-I receptor mutant leads to short stature: Clinical and biochemical characterization. J. Clin. Endocrinol. Metab. 2007, 92, 1542-1548.
41. Peoples, R.; Milatovich, A.; Francke, U. Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 1995, 70, 228-234.
42. Walenkamp, M.J.; de Muinck Keizer-Schrama, S.M.; de Mos, M.; Kalf, M.E.; van Duyvenvoorde, H.A.; Boot, A.M.; Kant, S.G.; White, S.J.; Losekoot, M.; Den Dunnen, J.T.; et al. Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplification. J. Clin. Endocrinol. Metab. 2008, 93, 2421-2425.
43. Van Duyvenvoorde, H.A.; van Doorn, J.; Koenig, J.; Gauguin, L.; Oostdijk, W.; Wade, J.D.; Karperien, M.; Ruivenkamp, C.A.; Losekoot, M.; van Setten, P.A.; et al. The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein. Growth Horm. IGF Res. 2011, 21, 44-50.
44. Fuqua, J.S.; Derr, M.; Rosenfeld, R.G.; Hwa, V. Identification of a novel heterozygous IGF1 splicing mutation in a large kindred with familial short stature. Horm. Res. Paediatr. 2012, 78, 59-66.
45. Mosier, H.D., Jr.; Jansons, R.A. Growth hormone during catch-up growth and failure of catch-up growth in rats. Endocrinology 1976, 98, 214-219.
46. Hermanussen, M.; Rol de Lama, M.A.; Romero, A.P.; Ruiz, C.A.; Burmeister, J.; Tresguerres, J.A. Differential catch-up in body weight and bone growth after short-term starvation in rats. Growth Regul. 1996, 6, 230-237.
47. Gat-Yablonski, G.; Shtaif, B.; Abraham, E.; Phillip, M. Nutrition-induced catch-up growth at the growth plate. J. Pediatr. Endocrinol. Metab. 2008, 21, 879-893.
48. Pando, R.; Shtaif, B.; Phillip, M.; Gat-Yablonski, G. A serum component mediates food restriction-induced growth attenuation. Endocrinology 2014, 155, 932-940.
49. Lowe, W.L., Jr.; Adamo, M.; Werner, H.; Roberts, C.T., Jr.; LeRoith, D. Regulation by fasting of rat insulin-like growth factor I and its receptor. Effects on gene expression and binding. J. Clin. Investig. 1989, 84, 619-626.
50. Maes, M.; Ketelslegers, J.M.; Underwood, L.E. Low circulating somatomedin-C/insulin-like growth factor I in insulin-dependent diabetes and malnutrition: Growth hormone receptor and post-receptor defects. Acta Endocrinol. Suppl. 1986, 279, 86-92.
51. Lee, P.D.; Suwanichkul, A.; DePaolis, L.A.; Snuggs, M.B.; Morris, S.L.; Powell, D.R. Insulin-like growth factor (IGF) suppression of IGFBP-1 production: Evidence for mediation by the type I IGF receptor. Regul. Pept. 1993, 48, 199-206.
52. Ben Lagha, N.; Seurin, D.; le Bouc, Y.; Binoux, M.; Berdal, A.; Menuelle, P.; Babajko, S. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: Study on IGFBP-1 overexpressing transgenic mice. Endocrinology 2006, 147, 4730-4737.
53. Cotterill, A.M.; Holly, J.M.; Wass, J.A. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clin. Endocrinol. 1993, 39, 357-362.
54. Woodall, S.M.; Breier, B.H.; Johnston, B.M.; Gluckman, P.D. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: Effects on the somatotrophic axis and postnatal growth. J. Endocrinol. 1996, 150, 231-242.
55. Straus, D.S.; Burke, E.J.; Marten, N.W. Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid. Endocrinology 1993, 132, 1090-1100.
56. Takenaka, A.; Komori, K.; Morishita, T.; Takahashi, S.I.; Hidaka, T.; Noguchi, T. Amino acid regulation of gene transcription of rat insulin-like growth factor-binding protein-1. J. Endocrinol. 2000, 164, R11-R16.
57. Henning, P.C.; Scofield, D.E.; Rarick, K.R.; Pierce, J.R.; Staab, J.S.; Lieberman, H.R.; Nindl, B.C. Effects of acute caloric restriction compared to caloric balance on the temporal response of the IGF-I system. Metabolism 2013, 62, 179-187.
58. Abu Shehab, M.; Iosef, C.; Wildgruber, R.; Sardana, G.; Gupta, M.B. Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation. Endocrinology 2013, 154, 1130-1143.
59. Yamanaka, Y.; Wilson, E.M.; Rosenfeld, R.G.; Oh, Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J. Biol. Chem. 1997, 272, 30729-30734.
60. Lui, J.C.; Forcinito, P.; Chang, M.; Chen, W.; Barnes, K.M.; Baron, J. Coordinated postnatal down-regulation of multiple growth-promoting genes: Evidence for a genetic program limiting organ growth. FASEB J. 2010, 24, 3083-3092.
61. Zhang, Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L.; Friedman, J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372, 425-432.
62. Pelleymounter, M.A.; Cullen, M.J.; Baker, M.B.; Hecht, R.; Winters, D.; Boone, T.; Collins, F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269, 540-543.
63. Campfield, L.A. Metabolic and hormonal controls of food intake: Highlights of the last 25 years-1972-1997. Appetite 1997, 29, 135-152.
64. Hoggard, N.; Mercer, J.G.; Rayner, D.V.; Moar, K.; Trayhurn, P.; Williams, L.M. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem. Biophys. Res. Commun. 1997, 232, 383-387.
65. Cohen, M.M., Jr. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am. J. Med. Genet. 2006, 140, 515-524.
66. Gat-Yablonski, G.; Ben-Ari, T.; Shtaif, B.; Potievsky, O.; Moran, O.; Eshet, R.; Maor, G.; Segev, Y.; Phillip, M. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 2004, 145, 343-350.
67. Ben-Eliezer, M.; Phillip, M.; Gat-Yablonski, G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 2007, 32, 235-244.
68. Karsenty, G. Leptin controls bone formation through a hypothalamic relay. Recent Prog. Horm. Res. 2001, 56, 401-415.
69. Turner, R.T.; Kalra, S.P.; Wong, C.P.; Philbrick, K.A.; Lindenmaier, L.B.; Boghossian, S.; Iwaniec, U.T. Peripheral leptin regulates bone formation. J. Bone Min. Res. 2013, 28, 22-34.
70. Grisaru-Granovsky, S.; Samueloff, A.; Elstein, D. The role of leptin in fetal growth: A short review from conception to delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 136, 146-150.
71. Apter, D. The role of leptin in female adolescence. Ann. N. Y. Acad. Sci. 2003, 997, 64-76.
72. Maqsood, A.R.; Trueman, J.A.; Whatmore, A.J.; Westwood, M.; Price, D.A.; Hall, C.M.; Clayton, P.E. The relationship between nocturnal urinary leptin and gonadotrophins as children progress towards puberty. Horm. Res. 2007, 68, 225-230.
73. Steppan, C.M.; Crawford, D.T.; Chidsey-Frink, K.L.; Ke, H.; Swick, A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept. 2000, 92, 73-78.
74. Iwaniec, U.T.; Boghossian, S.; Lapke, P.D.; Turner, R.T.; Kalra, S.P. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides 2007, 28, 1012-1019.
75. Carro, E.; Senaris, R.; Considine, R.V.; Casanueva, F.F.; Dieguez, C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997, 138, 2203-2206.
76. Jin, L.; Burguera, B.G.; Couce, M.E.; Scheithauer, B.W.; Lamsan, J.; Eberhardt, N.L.; Kulig, E.; Lloyd, R.V. Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role for leptin on pituitary cell proliferation. J. Clin. Endocrinol. Metab. 1999, 84, 2903-2911.
77. Goldstone, A.P.; Howard, J.K.; Lord, G.M.; Ghatei, M.A.; Gardiner, J.V.; Wang, Z.L.; Wang, R.M.; Girgis, S.I.; Bailey, C.J.; Bloom, S.R. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem. Biophys. Res. Commun. 2002, 295, 475-481.
78. Accorsi, P.A.; Munno, A.; Gamberoni, M.; Viggiani, R.; de Ambrogi, M.; Tamanini, C.; Seren, E. Role of leptin on growth hormone and prolactin secretion by bovine pituitary explants. J. Dairy Sci. 2007, 90, 1683-1691.
79. Maor, G.; Rochwerger, M.; Segev, Y.; Phillip, M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J. Bone Min. Res. 2002, 17, 1034-1043.
80. Ducy, P.; Amling, M.; Takeda, S.; Priemel, M.; Schilling, A.F.; Beil, F.T.; Shen, J.; Vinson, C.; Rueger, J.M.; Karsenty, G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000, 100, 197-207.
81. Hamrick, M.W.; Ding, K.H.; Ponnala, S.; Ferrari, S.L.; Isales, C.M. Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: Implications for the regulation of bone mass by body weight. J. Bone Min. Res. 2008, 23, 870-878.
82. Montague, C.T.; Farooqi, I.S.; Whitehead, J.P.; Soos, M.A.; Rau, H.; Wareham, N.J.; Sewter, C.P.; Digby, J.E.; Mohammed, S.N.; Hurst, J.A.; et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387, 903-908.
83. Farooqi, I.S.; Wangensteen, T.; Collins, S.; Kimber, W.; Matarese, G.; Keogh, J.M.; Lank, E.; Bottomley, B.; Lopez-Fernandez, J.; Ferraz-Amaro, I.; et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 2007, 356, 237-247.
84. Gat-Yablonski, G.; Shtaif, B.; Phillip, M. Leptin stimulates parathyroid hormone related peptide expression in the endochondral growth plate. J. Pediatr. Endocrinol. Metab. 2007, 20, 1215-1222.
85. Martin, A.; David, V.; Malaval, L.; Lafage-Proust, M.H.; Vico, L.; Thomas, T. Opposite effects of leptin on bone metabolism: A dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology 2007, 148, 3419-3425.
86. Devlin, M.J.; Cloutier, A.M.; Thomas, N.A.; Panus, D.A.; Lotinun, S.; Pinz, I.; Baron, R.; Rosen, C.J.; Bouxsein, M.L. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J. Bone Min. Res. 2010, 25, 2078-2088.
87. Bar-El Dadon, S.; Shahar, R.; Katalan, V.; Monsonego-Ornan, E.; Reifen, R. Leptin administration affects growth and skeletal development in a rat intrauterine growth restriction model: Preliminary study. Nutrition 2011, 27, 973-977.
88. LaPaglia, N.; Steiner, J.; Kirsteins, L.; Emanuele, M.; Emanuele, N. Leptin alters the response of the growth hormone releasing factor- growth hormone-Insulin-like growth factor-I axis to fasting. J. Endocrinol. 1998, 159, 79-83.
89. Underwood, L.E.; Clemmons, D.R.; Maes, M.; D'Ercole, A.J.; Ketelslegers, J.M. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm. Res. 1986, 24, 166-176.
90. Kume, K.; Satomura, K.; Nishisho, S.; Kitaoka, E.; Yamanouchi, K.; Tobiume, S.; Nagayama, M. Potential role of leptin in endochondral ossification. J. Histochem. Cytochem. 2002, 50, 159-169.
91. Nakajima, R.; Inada, H.; Koike, T.; Yamano, T. Effects of leptin to cultured growth plate chondrocytes. Horm. Res. 2003, 60, 91-98.
92. Steendijk, R. Remarkable catch-up growth in a boy with steroid-responsive nephrotic syndrome. Acta Endocrinol. Suppl. 1986, 279, 8-12.
93. Codoner-Franch, P.; Bernard, O.; Alvarez, F. Long-term follow-up of growth in height after successful liver transplantation. J. Pediatr. 1994, 124, 368-373.
94. Simon, D.; Lucidarme, N.; Prieur, A.M.; Ruiz, J.C.; Czernichow, P. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: Natural history and effects of growth hormone treatment on linear growth. J. Pediatr. Endocrinol. Metab. 2001, 14, 1483-1486.
95. Pass, C.; MacRae, V.E.; Ahmed, S.F.; Farquharson, C. Inflammatory cytokines and the GH/IGF-I axis: Novel actions on bone growth. Cell Biochem. Funct. 2009, 27, 119-127.
96. Kato, Y.; Gospodarowicz, D. Stimulation by glucocorticoid of the synthesis of cartilage-matrix proteoglycans produced by rabbit costal chondrocytes in vitro. J. Biol. Chem. 1985, 260, 2364-2373.
97. Schrier, L.; Ferns, S.P.; Barnes, K.M.; Emons, J.A.; Newman, E.I.; Nilsson, O.; Baron, J. Depletion of resting zone chondrocytes during growth plate senescence. J. Endocrinol. 2006, 189, 27-36.
98. Chagin, A.S.; Karimian, E.; Sundstrom, K.; Eriksson, E.; Savendahl, L. Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones. J. Endocrinol. 2010, 204, 21-29.
99. Mushtaq, T.; Farquharson, C.; Seawright, E.; Ahmed, S.F. Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J. Endocrinol. 2002, 175, 705-713.
100. Jux, C.; Leiber, K.; Hugel, U.; Blum, W.; Ohlsson, C.; Klaus, G.; Mehls, O. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 1998, 139, 3296-3305.
101. Robson, H.; Phillip, M.; Wit, J.M. The Second European Growth Plate Working Group Symposium 25th September 2002, Madrid, Spain. J. Pediatr. Endocrinol. Metab. 2003, 16, 461-466.
102. Luo, J.; Reid, R.E.; Murphy, L.J. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 1990, 127, 1456-1462.
103. Robson, H.; Siebler, T.; Stevens, D.A.; Shalet, S.M.; Williams, G.R. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 2000, 141, 3887-3897.
104. Kaneshige, M.; Suzuki, H.; Kaneshige, K.; Cheng, J.; Wimbrow, H.; Barlow, C.; Willingham, M.C.; Cheng, S. A targeted dominant negative mutation of the thyroid hormone α 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc. Natl. Acad. Sci. USA 2001, 98, 15095-15100.
105. Maglich, J.M.; Watson, J.; McMillen, P.J.; Goodwin, B.; Willson, T.M.; Moore, J.T. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J. Biol. Chem. 2004, 279, 19832-19838.
106. Herlihy, J.T.; Stacy, C.; Bertrand, H.A. Long-term food restriction depresses serum thyroid hormone concentrations in the rat. Mech. Ageing Dev. 1990, 53, 9-16.
107. DeLany, J.P.; Hansen, B.C.; Bodkin, N.L.; Hannah, J.; Bray, G.A. Long-term calorie restriction reduces energy expenditure in aging monkeys. J. Gerontol. A Biol. Sci. Med. Sci. 1999, 54, 5-13.
108. Roth, G.S.; Handy, A.M.; Mattison, J.A.; Tilmont, E.M.; Ingram, D.K.; Lane, M.A. Effects of dietary caloric restriction and aging on thyroid hormones of rhesus monkeys. Horm. Metab. Res. 2002, 34, 378-382.
109. Bassett, J.H.; Swinhoe, R.; Chassande, O.; Samarut, J.; Williams, G.R. Thyroid hormone regulates heparan sulfate proteoglycan expression in the growth plate. Endocrinology 2006, 147, 295-305.
110. Long, Y.C.; Kharitonenkov, A. Hormone-like fibroblast growth factors and metabolic regulation. Biochim. Biophys. Acta 2011, 1812, 791-795.
111. Kharitonenkov, A.; Shiyanova, T.L.; Koester, A.; Ford, A.M.; Micanovic, R.; Galbreath, E.J.; Sandusky, G.E.; Hammond, L.J.; Moyers, J.S.; Owens, R.A.; et al. FGF-21 as a novel metabolic regulator. J. Clin. Investig. 2005, 115, 1627-1635.
112. Kharitonenkov, A.; Wroblewski, V.J.; Koester, A.; Chen, Y.F.; Clutinger, C.K.; Tigno, X.T.; Hansen, B.C.; Shanafelt, A.B.; Etgen, G.J. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007, 148, 774-781.
113. Yang, M.; Dong, J.; Liu, H.; Li, L.; Yang, G. Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus. PLoS One 2011, 6, e26359.
114. Zhang, X.; Yeung, D.C.; Karpisek, M.; Stejskal, D.; Zhou, Z.G.; Liu, F.; Wong, R.L.; Chow, W.S.; Tso, A.W.; Lam, K.S.; et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008, 57, 1246-1253.
115. Reinehr, T.; Woelfle, J.; Wunsch, R.; Roth, C.L. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: A longitudinal analysis. J. Clin. Endocrinol. Metab. 2012, 97, 2143-2150.
116. Giannini, C.; Feldstein, A.E.; Santoro, N.; Kim, G.; Kursawe, R.; Pierpont, B.; Caprio, S. Circulating levels of FGF-21 in obese youth: Associations with liver fat content and markers of liver damage. J. Clin. Endocrinol. Metab. 2013, 98, 2993-3000.
117. Lundasen, T.; Andersson, E.M.; Snaith, M.; Lindmark, H.; Lundberg, J.; Ostlund-Lindqvist, A.M.; Angelin, B.; Rudling, M. Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice. PLoS One 2012, 7, e37787.
118. Ables, G.P.; Perrone, C.E.; Orentreich, D.; Orentreich, N. Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS One 2012, 7, e51357.
119. Nygaard, E.B.; Moller, C.L.; Kievit, P.; Grove, K.L.; Andersen, B. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). Int. J. Obes. 2014, 38, 183-191.
120. Badman, M.K.; Pissios, P.; Kennedy, A.R.; Koukos, G.; Flier, J.S.; Maratos-Flier, E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007, 5, 426-437.
121. Kubicky, R.A.; Wu, S.; Kharitonenkov, A.; de Luca, F. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 2012, 153, 2287-2295.
122. Galman, C.; Lundasen, T.; Kharitonenkov, A.; Bina, H.A.; Eriksson, M.; Hafstrom, I.; Dahlin, M.; Amark, P.; Angelin, B.; Rudling, M. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man. Cell Metab. 2008, 8, 169-174.
123. Mai, K.; Schwarz, F.; Bobbert, T.; Andres, J.; Assmann, A.; Pfeiffer, A.F.; Spranger, J. Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction. Metabolism 2011, 60, 306-311.
124. Wu, S.; Levenson, A.; Kharitonenkov, A.; de Luca, F. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J. Biol. Chem. 2012, 287, 26060-26067.
125. Inagaki, T.; Lin, V.Y.; Goetz, R.; Mohammadi, M.; Mangelsdorf, D.J.; Kliewer, S.A. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008, 8, 77-83.
126. Wu, S.; Grunwald, T.; Kharitonenkov, A.; Dam, J.; Jockers, R.; de Luca, F. Increased expression of fibroblast growth factor 21 (FGF21) during chronic undernutrition causes growth hormone insensitivity in chondrocytes by inducing leptin receptor overlapping transcript (LEPROT) and leptin receptor overlapping transcript-like 1 (LEPROTL1) expression. J. Biol. Chem. 2013, 288, 27375-27383.
127. Hondares, E.; Rosell, M.; Gonzalez, F.J.; Giralt, M.; Iglesias, R.; Villarroya, F. Hepatic FGF21 expression is induced at birth via response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab. 2010, 11, 206-212.
128. Curtis, K.M.; Aenlle, K.K.; Roos, B.A.; Howard, G.A. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells. Mol. Endocrinol. 2014, 28, 644-658.
129. Schwartz, Z.; Sylvia, V.L.; Luna, M.H.; deVeau, P.; Whetstone, R.; Dean, D.D.; Boyan, B.D. The effect of 24R,25-(OH)2D3 on protein kinase C activity in chondrocytes is mediated by phospholipase D whereas the effect of 1α,25-(OH)2D3 is mediated by phospholipase C. Steroids 2001, 66, 683-694.
130. Boyan, B.D.; Jennings, E.G.; Wang, L.; Schwartz, Z. Mechanisms regulating differential activation of membrane-mediated signaling by 1α,25(OH)2D3 and 24R,25(OH)2D3. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 309-315.
131. Boyan, B.D.; Schwartz, Z. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells Tissues Organs 2009, 189, 70-74.
132. Van der Meijden, K.; Lips, P.; van Driel, M.; Heijboer, A.C.; Schulten, E.A.; den Heijer, M.; Bravenboer, N. Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3. PLoS One 2014, 9, e110283.
133. D'Alesio, A.; Garabedian, M.; Sabatier, J.P.; Guaydier-Souquieres, G.; Marcelli, C.; Lemacon, A.; Walrant-Debray, O.; Jehan, F. Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum. Mol. Genet. 2005, 14, 3539-3548.
134. Dempfle, A.;Wudy, S.A.; Saar, K.; Hagemann, S.; Friedel, S.; Scherag, A.; Berthold, L.D.; Alzen, G.; Gortner, L.; Blum, W.F.; et al. Evidence for involvement of the vitamin D receptor gene in idiopathic short stature via a genome-wide linkage study and subsequent association studies. Hum. Mol. Genet. 2006, 15, 2772-2783.
135. Jorde, R.; Svartberg, J.; Joakimsen, R.M.; Grimnes, G. Associations between polymorphisms related to calcium metabolism and human height: The Tromso Study. Ann. Hum. Genet. 2012, 76, 200-210.
136. Li, Y.C.; Pirro, A.E.; Amling, M.; Delling, G.; Baron, R.; Bronson, R.; Demay, M.B. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94, 9831-9835.
137. Donohue, M.M.; Demay, M.B. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002, 143, 3691-3694.
138. Saini, H.K.; Griffiths-Jones, S.; Enright, A.J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. USA 2007, 104, 17719-17724.
139. Chen, K.; Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8, 93-103.
140. He, L.; Hannon, G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5, 522-531.
141. Esau, C.; Kang, X.; Peralta, E.; Hanson, E.; Marcusson, E.G.; Ravichandran, L.V.; Sun, Y.; Koo, S.; Perera, R.J.; Jain, R.; et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004, 279, 52361-52365.
142. Lovis, P.; Gattesco, S.; Regazzi, R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem. 2008, 389, 305-312.
143. Krutzfeldt, J.; Stoffel, M. MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab. 2006, 4, 9-12.
144. McManus, M.T. MicroRNAs and cancer. Semin. Cancer Biol. 2003, 13, 253-258.
145. Wilson, A.J.; Byun, D.S.; Nasser, S.; Murray, L.; Ayyanar, K.; Arango, D.; Figueroa, M.; Melnick, A.; Kao, G.D.; Augenlicht, L.H.; Mariadason, J.M. HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21. Mol. Biol. Cell 2008, 19, 4062-4075.
146. Nelson, P.T.; Wang, W.X.; Rajeev, B.W. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain. Pathol. 2008, 18, 130-138.
147. Bernstein, E.; Kim, S.Y.; Carmell, M.A.; Murchison, E.P.; Alcorn, H.; Li, M.Z.; Mills, A.A.; Elledge, S.J.; Anderson, K.V.; Hannon, G.J. Dicer is essential for mouse development. Nat. Genet. 2003, 35, 215-217.
148. Kobayashi, T.; Lu, J.; Cobb, B.S.; Rodda, S.J.; McMahon, A.P.; Schipani, E.; Merkenschlager, M.; Kronenberg, H.M. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc. Natl. Acad. Sci. USA 2008, 105, 1949-1954.
149. Harfe, B.D.; McManus, M.T.; Mansfield, J.H.; Hornstein, E.; Tabin, C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. USA 2005, 102, 10898-10903.
150. Wienholds, E.; Kloosterman, W.P.; Miska, E.; Alvarez-Saavedra, E.; Berezikov, E.; de Bruijn, E.; Horvitz, H.R.; Kauppinen, S.; Plasterk, R.H. MicroRNA expression in zebrafish embryonic development. Science 2005, 309, 310-311.
151. Tuddenham, L.; Wheeler, G.; Ntounia-Fousara, S.; Waters, J.; Hajihosseini, M.K.; Clark, I.; Dalmay, T. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006, 580, 4214-4217.
152. Guan, Y.J.; Yang, X.; Wei, L.; Chen, Q. MiR-365: A mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 2011, 25, 4457-4466.
153. Lin, E.A.; Kong, L.; Bai, X.H.; Luan, Y.; Liu, C.J. miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J. Biol. Chem. 2009, 284, 11326-11335.
154. Papaioannou, G.; Inloes, J.B.; Nakamura, Y.; Paltrinieri, E.; Kobayashi, T. let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc. Natl. Acad. Sci. USA 2013, 110, E3291-E3300.
155. Eberhart, J.K.; He, X.; Swartz, M.E.; Yan, Y.L.; Song, H.; Boling, T.C.; Kunerth, A.K.; Walker, M.B.; Kimmel, C.B.; Postlethwait, J.H. MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat. Genet. 2008, 40, 290-298.
156. Nicolas, F.E.; Pais, H.; Schwach, F.; Lindow, M.; Kauppinen, S.; Moulton, V.; Dalmay, T. mRNA expression profiling reveals conserved and non-conserved miR-140 targets. RNA Biol. 2011, 8, 607-615.
157. Miyaki, S.; Sato, T.; Inoue, A.; Otsuki, S.; Ito, Y.; Yokoyama, S.; Kato, Y.; Takemoto, F.; Nakasa, T.; Yamashita, S.; et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010, 24, 1173-1185.
158. Zhang, J.; Yang, Y.; Yang, T.; Liu, Y.; Li, A.; Fu, S.; Wu, M.; Pan, Z.; Zhou, W. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 2010, 103, 1215-1220.
159. Huang, Z.P.; Chen, J.; Seok, H.Y.; Zhang, Z.; Kataoka, M.; Hu, X.; Wang, D.Z. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 2013, 112, 1234-1243.
160. Xu, D.; Takeshita, F.; Hino, Y.; Fukunaga, S.; Kudo, Y.; Tamaki, A.; Matsunaga, J.; Takahashi, R.U.; Takata, T.; Shimamoto, A.; et al. miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 2011, 193, 409-424.
161. Tsuchiya, N.; Izumiya, M.; Ogata-Kawata, H.; Okamoto, K.; Fujiwara, Y.; Nakai, M.; Okabe, A.; Schetter, A.J.; Bowman, E.D.; Midorikawa, Y.; et al. Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res. 2011, 71, 4628-4639.
162. Xiong, J. Key roles of microRNA-22 family in complex organisms inferred from its evolution. Microrna 2014, 3, 64-74.
163. Vega, R.B.; Matsuda, K.; Oh, J.; Barbosa, A.C.; Yang, X.; Meadows, E.; McAnally, J.; Pomajzl, C.; Shelton, J.M.; Richardson, J.A.; et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119, 555-566.
164. Colnot, C. Cellular and molecular interactions regulating skeletogenesis. J. Cell Biochem. 2005, 95, 688-697.
165. Nicolas, F.E.; Pais, H.; Schwach, F.; Lindow, M.; Kauppinen, S.; Moulton, V.; Dalmay, T. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008, 14, 2513-2520.
166. Tavazoie, S.F.; Alarcon, C.; Oskarsson, T.; Padua, D.; Wang, Q.; Bos, P.D.; Gerald, W.L.; Massague, J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451, 147-152.
167. Chan, J.A.; Krichevsky, A.M.; Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65, 6029-6033.
168. Han, E.S.; Hickey, M. Microarray evaluation of dietary restriction. J. Nutr. 2005, 135, 1343-1346.
169. Schipani, E.; Ryan, H.E.; Didrickson, S.; Kobayashi, T.; Knight, M.; Johnson, R.S. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 2001, 15, 2865-2876.
170. Schipani, E. Hypoxia and HIF-1α in chondrogenesis. Semin. Cell Dev. Biol. 2005, 16, 539-546.
171. Schipani, E. Posttranslational modifications of collagens as targets of hypoxia and Hif-1α in endochondral bone development. Ann. N. Y. Acad. Sci. 2010, 1192, 317-321.
172. Lee, S.H.; Che, X.; Jeong, J.H.; Choi, J.Y.; Lee, Y.J.; Lee, Y.H.; Bae, S.C.; Lee, Y.M. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. J. Biol. Chem. 2012, 287, 14760-14771.
173. Klionsky, D.J. The correct way to monitor autophagy in higher eukaryotes. Autophagy 2005, 1, 65.
174. Levine, B.; Klionsky, D.J. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6, 463-477.
175. Srinivas, V.; Shapiro, I.M. Chondrocytes embedded in the epiphyseal growth plates of long bones undergo autophagy prior to the induction of osteogenesis. Autophagy 2006, 2, 215-216.
176. Srinivas, V.; Bohensky, J.; Shapiro, I.M. Autophagy: A new phase in the maturation of growth plate chondrocytes is regulated by HIF, mTOR and AMP kinase. Cells Tissues Organs 2009, 189, 88-92.
177. Fullgrabe, J.; Klionsky, D.J.; Joseph, B. The return of the nucleus: Transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol. 2014, 15, 65-74.
178. Si, M.L.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y.Y. miR-21-mediated tumor growth. Oncogene 2007, 26, 2799-2803.
179. Tokunaga, C.; Yoshino, K.; Yonezawa, K. mTOR integrates amino acid- and energy-sensing pathways. Biochem. Biophys. Res. Commun. 2004, 313, 443-446.
180. Kim, D.H.; Sarbassov, D.D.; Ali, S.M.; King, J.E.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110, 163-175.
181. Kim, D.H.; Sarbassov, D.D.; Ali, S.M.; Latek, R.R.; Guntur, K.V.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 2003, 11, 895-904.
182. Sarbassov, D.D.; Ali, S.M.; Kim, D.H.; Guertin, D.A.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004, 14, 1296-1302.
183. Frias, M.A.; Thoreen, C.C.; Jaffe, J.D.; Schroder, W.; Sculley, T.; Carr, S.A.; Sabatini, D.M. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 2006, 16, 1865-1870.
184. Wullschleger, S.; Loewith, R.; Hall, M.N. TOR signaling in growth and metabolism. Cell 2006, 124, 471-484.
185. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 2004, 18, 1926-1945.
186. Pullen, N.; Thomas, G. The modular phosphorylation and activation of p70s6k. FEBS Lett. 1997, 410, 78-82.
187. Saitoh, M.; Pullen, N.; Brennan, P.; Cantrell, D.; Dennis, P.B.; Thomas, G. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem. 2002, 277, 20104-20112.
188. Backer, J.M. The regulation and function of Class III PI3Ks: Novel roles for Vps34. Biochem. J. 2008, 410, 1-17.
189. Jewell, J.L.; Russell, R.C.; Guan, K.L. Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 2013, 14, 133-139.
190. Phornphutkul, C.; Wu, K.Y.; Auyeung, V.; Chen, Q.; Gruppuso, P.A. mTOR signaling contributes to chondrocyte differentiation. Dev. Dyn. 2008, 237, 702-712.
191. Savabi, F. Interaction of creatine kinase and adenylate kinase systems in muscle cells. Mol. Cell. Biochem. 1994, 133-134, 145-152.
192. Bohensky, J.; Leshinsky, S.; Srinivas, V.; Shapiro, I.M. Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr. Nephrol. 2010, 25, 633-642.
193. Bellot, G.; Garcia-Medina, R.; Gounon, P.; Chiche, J.; Roux, D.; Pouyssegur, J.; Mazure, N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 2009, 29, 2570-2581.
194. Sterner, D.E.; Berger, S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64, 435-459.
195. Chiba, T.; Yokosuka, O.; Fukai, K.; Kojima, H.; Tada, M.; Arai, M.; Imazeki, F.; Saisho, H. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. Oncology 2004, 66, 481-491.
196. Bolden, J.E.; Peart, M.J.; Johnstone, R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5, 769-784.
197. De Ruijter, A.J.; van Gennip, A.H.; Caron, H.N.; Kemp, S.; van Kuilenburg, A.B. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 2003, 370, 737-749.
198. Gao, L.; Cueto, M.A.; Asselbergs, F.; Atadja, P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 2002, 277, 25748-25755.
199. Funato, H.; Oda, S.; Yokofujita, J.; Igarashi, H.; Kuroda, M. Fasting and high-fat diet alter histone deacetylase expression in the medial hypothalamus. PLoS One 2011, 6, e18950.
200. Furumatsu, T.; Tsuda, M.; Yoshida, K.; Taniguchi, N.; Ito, T.; Hashimoto, M.; Ito, T.; Asahara, H. Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J. Biol. Chem. 2005, 280, 35203-35208.
201. Hong, S.; Derfoul, A.; Pereira-Mouries, L.; Hall, D.J. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 2009, 23, 3539-3552.
202. Bradley, E.W.; Carpio, L.R.; Westendorf, J.J. Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J. Biol. Chem. 2013, 288, 9572-9582.
203. Kanfi, Y.; Peshti, V.; Gozlan, Y.M.; Rathaus, M.; Gil, R.; Cohen, H.Y. Regulation of SIRT1 protein levels by nutrient availability. FEBS Lett. 2008, 582, 2417-2423.
204. Kanfi, Y.; Shalman, R.; Peshti, V.; Pilosof, S.N.; Gozlan, Y.M.; Pearson, K.J.; Lerrer, B.; Moazed, D.; Marine, J.C.; de Cabo, R.; et al. Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett. 2008, 582, 543-548.
205. McBurney, M.W.; Yang, X.; Jardine, K.; Hixon, M.; Boekelheide, K.; Webb, J.R.; Lansdorp, P.M.; Lemieux, M. The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 2003, 23, 38-54.
206. Picard, F.; Kurtev, M.; Chung, N.; Topark-Ngarm, A.; Senawong, T.; Machado De Oliveira, R.; Leid, M.; McBurney, M.W.; Guarente, L. SIRT1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 2004, 429, 771-776.
207. Rodgers, J.T.; Lerin, C.; Haas, W.; Gygi, S.P.; Spiegelman, B.M.; Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 2005, 434, 113-118.
208. Nemoto, S.; Fergusson, M.M.; Finkel, T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306, 2105-2108.
209. Jing, E.; Gesta, S.; Kahn, C.R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 2007, 6, 105-114.
210. Cheng, H.L.; Mostoslavsky, R.; Saito, S.; Manis, J.P.; Gu, Y.; Patel, P.; Bronson, R.; Appella, E.; Alt, F.W.; Chua, K.F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100, 10794-10799.
211. Rubinsztein, D.C.; Marino, G.; Kroemer, G. Autophagy and aging. Cell 2011, 146, 682-695.
212. Ghosh, H.S.; McBurney, M.; Robbins, P.D. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 2010, 5, e9199.
213. Lee, I.H.; Cao, L.; Mostoslavsky, R.; Lombard, D.B.; Liu, J.; Bruns, N.E.; Tsokos, M.; Alt, F.W.; Finkel, T. A role for the NAD-dependent deacetylase SIRT1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA 2008, 105, 3374-3379.
214. Lim, J.H.; Lee, Y.M.; Chun, Y.S.; Chen, J.; Kim, J.E.; Park, J.W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol. Cell 2010, 38, 864-878.
215. Monteserin-Garcia, J.; Al-Massadi, O.; Seoane, L.M.; Alvarez, C.V.; Shan, B.; Stalla, J.; Paez-Pereda, M.; Casanueva, F.F.; Stalla, G.K.; Theodoropoulou, M. Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB J. 2013, 27, 1561-1571.
216. Yamamoto, M.; Iguchi, G.; Fukuoka, H.; Suda, K.; Bando, H.; Takahashi, M.; Nishizawa, H.; Seino, S.; Takahashi, Y. SIRT1 regulates adaptive response of the growth hormone-Insulin-like growth factor-I axis under fasting conditions in liver. Proc. Natl. Acad. Sci. USA 2013, 110, 14948-14953.
217. Gan, L.; Han, Y.; Bastianetto, S.; Dumont, Y.; Unterman, T.G.; Quirion, R. FoxO-dependent and -independent mechanisms mediate SIRT1 effects on IGFBP-1 gene expression. Biochem. Biophys. Res. Commun. 2005, 337, 1092-1096.
218. Li, P.; Liang, M.L.; Zhu, Y.; Gong, Y.Y.; Wang, Y.; Heng, D.; Lin, L. Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts. World J. Gastroenterol. 2014, 20, 4648-4661.
219. Mostoslavsky, R.; Chua, K.F.; Lombard, D.B.; Pang, W.W.; Fischer, M.R.; Gellon, L.; Liu, P.; Mostoslavsky, G.; Franco, S.; Murphy, M.M.; et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124, 315-329.
220. Schwer, B.; Schumacher, B.; Lombard, D.B.; Xiao, C.; Kurtev, M.V.; Gao, J.; Schneider, J.I.; Chai, H.; Bronson, R.T.; Tsai, L.H.; et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc. Natl. Acad. Sci. USA 2010, 107, 21790-21794.
221. Piao, J.; Tsuji, K.; Ochi, H.; Iwata, M.; Koga, D.; Okawa, A.; Morita, S.; Takeda, S.; Asou, Y. Sirt6 regulates postnatal growth plate differentiation and proliferation via Ihh signaling. Sci. Rep. 2013, 3, 3022.
222. Sundaresan, N.R.; Vasudevan, P.; Zhong, L.; Kim, G.; Samant, S.; Parekh, V.; Pillai, V.B.; Ravindra, P.V.; Gupta, M.; Jeevanandam, V.; et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med. 2012, 18, 1643-1650.
223. Takasaka, N.; Araya, J.; Hara, H.; Ito, S.; Kobayashi, K.; Kurita, Y.; Wakui, H.; Yoshii, Y.; Yumino, Y.; Fujii, S.; et al. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J. Immunol. 2014, 192, 958-968.
224. Zhong, L.; D'Urso, A.; Toiber, D.; Sebastian, C.; Henry, R.E.; Vadysirisack, D.D.; Guimaraes, A.; Marinelli, B.; Wikstrom, J.D.; Nir, T.; et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 2010, 140, 280-293.
225. Nobili, V.; Alisi, A.; Panera, N.; Agostoni, C. Low birth weight and catch-up-growth associated with metabolic syndrome: A ten year systematic review. Pediatr. Endocrinol. Rev. 2008, 6, 241-247.
226. Pando, R.; Masarwi, M.; Shtaif, B.; Idelevich, A.; Monsonego-Ornan, E.; Shahar, R.; Phillip, M.; Gat-Yablonski, G. Bone quality is affected by food restriction and by nutrition-induced catch-up growth. J. Endocrinol. 2014, 223, 227-239.